Han et al. proposed that fibronectin stimulates non-small cell lung carcinoma cell growth and survival through the activation of the Akt/mTOR/p70S6K pathway [25], and recently, fibronectin has been implicated in carcinoma development as a potential biomarker for radioresistance [14]. This evidence concerns the gene MTOR and carcinoma.